What is Clinical Research Optimized™?
Biorasi is not just a contract research organization. We are a new kind of CRO, dedicated to delivering Clinical Research Optimized™ for our sponsors. We believe that the contract research organization industry is failing sponsors, and we strive achieve the ideal balance of cost, time and risk for our sponsors in every trial . Through innovative processes and technologies, dedication to sponsors, and a culture of ownership, our team will deliver your trial on time and on budget, every time.
KEEP YOUR CLINICAL TRIALS ON TARGET
Biorasi is recognized as a leading expert in delivering success where other CROs fail.
We are a trial rescue expert, recognized for our ability to complete trials that much larger CROs falter on. In our 15 years of experience, we’ve been able to rescue clinical trials from some of the leading names in pharma, lead by some of the most prominent contract research organizations in the world. Our rescue expertise doesn’t just save our sponsors time and money – it saves entire drug development programs.
"One of the rarest events, where we had to communicate [to Biorasi] to stop the screening rather than boost it."VP of Global Clinical Development, Top Specialty Pharma
Leading Global, Full-Service CRO Expands Clinical Trial Management Presence in Asia Biorasi, a leading full-service global CRO, is pleased to announce today the opening of their new Japanese office, located in Tokyo. This milestone marks Biorasi’s first regional...read more
Introduction Stem Cell Therapy is one of the most important biomedical discoveries in recent history, with far-reaching potential effects on a wide range on individuals afflicted with numerous diseases. Nonetheless, basic knowledge about Stem Cells - their sources,...read more
With the holiday season upon us, the focus shifts from daily work tasks to planning for vacations and festivities. The holidays can be especially challenging in clinical research where strict adherence to timelines is imperative for success. Many common holiday...read more
Stem Cell therapy constitutes one of the most hailed advents in medicine for its potential in treating many of the chronic and difficult diseases like Traumatic Brain Injury, Diabetes and Cancer. However, a huge cloud of myths and misconceptions surrounds this topic,...read more
With a global market of USD 3.3 billion during 2016 and a forecast surpassing USD 10.5 billion by 2023, Biosimilars have received more than their fair share of hype in the pharma world due to the undeniable value they bring to the healthcare system in terms of...read more
Immunoglobulin A (IgA) is an antibody manufactured by the body’s immune system to protect against invaders. Immunoglobulin A nephropathy (IgAN) is a common kidney disease where too much IgA is deposited into the kidneys causing severe inflammation and damage to the...read more